Advil-maker Haleon boosts US sales by targeting consumers on weight-loss drugs
Haleon said dual placement in stores lifted sales 24% per store as about 11% of Americans use GLP-1 weight-loss drugs.
6 Articles
6 Articles
The health product company Haleon has recorded increased sales of products intended to combat the side effects of weight loss medications in the United States, reported the company. Medicines such as Wegovy, from Novo Nordisk, and Zepbound and Foundayo, from Eli Lilly, help people lose weight by imitating a hormone that keeps the feeling of satiety in the stomach. But they have as possible side effects nausea, vomiting, stomach arrest and diarrh…
Advil-maker Haleon boosts US sales by targeting consumers on weight-loss drugs
By Richa Naidu LONDON, Sept 16 (Reuters) - Consumer health company Haleon has achieved growing sales of products to counter side-effects of weight-loss drugs in the United States, the company said, capitalising on the rising popularity of GLP-1 medic...
Haleon Boosts Sales with GLP-1 Drug Side-Effect Solutions in U.S.
Haleon, a consumer health company, reports increased sales of products designed to alleviate side effects from popular GLP-1 weight-loss drugs in the U.S. By strategically placing its products in dedicated and regular aisles, Haleon is capitalizing on the growing demand for solutions to nausea, constipation, and more.
Coverage Details
Bias Distribution
- 60% of the sources lean Left
Factuality
To view factuality data please Upgrade to Premium
